DD150430A5 - Verfahren zur herstellung von nicht oder nur gering irritierenden und/oder promovierenden diterpenalkoholen und von derivaten davon - Google Patents

Verfahren zur herstellung von nicht oder nur gering irritierenden und/oder promovierenden diterpenalkoholen und von derivaten davon Download PDF

Info

Publication number
DD150430A5
DD150430A5 DD80218582A DD21858280A DD150430A5 DD 150430 A5 DD150430 A5 DD 150430A5 DD 80218582 A DD80218582 A DD 80218582A DD 21858280 A DD21858280 A DD 21858280A DD 150430 A5 DD150430 A5 DD 150430A5
Authority
DD
German Democratic Republic
Prior art keywords
esters
phorbol
irritating
diterpenes
polyfunctional
Prior art date
Application number
DD80218582A
Other languages
German (de)
English (en)
Inventor
Erich Hecker
Hans Osswald
Rainer Schmidt
Hans J Opferkuch
Bernd Sorg
Walter Adolf
Mahmoud Youssef
Original Assignee
Deutsches Krebsforsch
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Deutsches Krebsforsch filed Critical Deutsches Krebsforsch
Publication of DD150430A5 publication Critical patent/DD150430A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/703—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups
    • C07C49/723—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups polycyclic
    • C07C49/727—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups polycyclic a keto group being part of a condensed ring system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/703—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups
    • C07C49/743—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups having unsaturation outside the rings, e.g. humulones, lupulones

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Treatments Of Macromolecular Shaped Articles (AREA)
DD80218582A 1979-01-23 1980-01-22 Verfahren zur herstellung von nicht oder nur gering irritierenden und/oder promovierenden diterpenalkoholen und von derivaten davon DD150430A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19792902506 DE2902506A1 (de) 1979-01-23 1979-01-23 Verwendung von nicht oder nur gering irritierenden und/oder promovierenden diterpenalkoholen und von derivaten davon als antineoplastische mittel

Publications (1)

Publication Number Publication Date
DD150430A5 true DD150430A5 (de) 1981-09-02

Family

ID=6061217

Family Applications (1)

Application Number Title Priority Date Filing Date
DD80218582A DD150430A5 (de) 1979-01-23 1980-01-22 Verfahren zur herstellung von nicht oder nur gering irritierenden und/oder promovierenden diterpenalkoholen und von derivaten davon

Country Status (15)

Country Link
US (1) US4716179A (fr)
EP (1) EP0013983B1 (fr)
JP (1) JPS55136221A (fr)
AT (1) ATE8203T1 (fr)
AU (1) AU529955B2 (fr)
CA (1) CA1160953A (fr)
DD (1) DD150430A5 (fr)
DE (1) DE2902506A1 (fr)
DK (1) DK26180A (fr)
FI (1) FI800171A7 (fr)
IE (1) IE50419B1 (fr)
MC (1) MC1298A1 (fr)
NO (1) NO800148L (fr)
YU (1) YU17880A (fr)
ZA (1) ZA80403B (fr)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5886019A (en) * 1986-06-11 1999-03-23 Procyon Pharmaceuticals, Inc. Protein kinase C modulators. F.
US5750568A (en) * 1986-06-11 1998-05-12 Procyon Pharmaceuticals, Inc. Protein kinase C Modulators. L.
US6080784A (en) * 1986-06-11 2000-06-27 Procyon Pharmaceuticals, Inc. Protein kinase C modulators N
US6043270A (en) * 1986-06-11 2000-03-28 Procyon Pharmaceuticals, Inc. Protein kinase C modulators V
US5716968A (en) * 1986-06-11 1998-02-10 Procyon Pharmaceuticals, Inc. Protein kinase C modulators. H.
US5891906A (en) * 1986-06-11 1999-04-06 Procyon Pharmaceuticals, Inc. Polyacetate-derived phorboids having anti-inflammatory and other uses
US5955501A (en) * 1986-06-11 1999-09-21 Procyon Pharmaceuticals, Inc. Protein kinase C modulators O
US5962498A (en) * 1986-06-11 1999-10-05 Procyon Pharmaceuticals, Inc. Protein kinase C modulators. C. indolactam structural-types with anti-inflammatory activity
US5891870A (en) * 1986-06-11 1999-04-06 Procyon Pharmaceuticals, Inc. Protein kinase C modulators Q
US4818359A (en) * 1986-08-27 1989-04-04 International Business Machines Corporation Low contamination RF sputter deposition apparatus
US4939149A (en) * 1988-10-24 1990-07-03 The United States Of America As Represented By The Department Of Health And Human Services Resiniferatoxin and analogues thereof to cause sensory afferent C-fiber and thermoregulatory desensitization
US5021450A (en) * 1989-05-30 1991-06-04 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services New class of compounds having a variable spectrum of activities for capsaicin-like responses, compositions and uses thereof
DE4005159A1 (de) * 1990-02-17 1991-08-22 Merck Patent Gmbh Diterpene mit immunmodulatorischer wirkung
US5405875A (en) * 1991-04-08 1995-04-11 The United States Of America As Represented By The Department Of Health And Human Services Method of inhibiting neoplasia and tumor promotion
AU1783092A (en) * 1991-04-08 1992-11-02 United States Of America, As Represented By The Secretary, Department Of Health And Human Services, The Inhibitors of protein kinase c function
AUPO864097A0 (en) 1997-08-19 1997-09-11 Peplin Pty Ltd Anti-cancer compounds
KR100336982B1 (ko) 1998-12-31 2002-05-17 성재갑 피부 미백용 조성물
AUPQ801700A0 (en) * 2000-06-07 2000-06-29 Peplin Research Pty Ltd Enzyme and viral activation
AUPQ923100A0 (en) 2000-08-07 2000-08-31 Peplin Research Pty Ltd Treatment of prostate cancer
GB0126000D0 (en) * 2001-10-30 2001-12-19 Univ Dundee Use of 4ñ Phorbol
DE10233737A1 (de) * 2002-07-24 2004-02-05 Morphochem Aktiengesellschaft für kombinatorische Chemie Verwendung von Modulatoren des Signaltransduktionswegs über die Proteinkinase Fyn zur Behandlung von Tumorerkrankungen
US7208183B2 (en) * 2002-10-05 2007-04-24 Bobrowski Paul J Methods and preparations of the latex from the croton species
CA2589992C (fr) 2004-12-13 2014-04-22 Peplin Research Pty Ltd Traitement de cancers solides
KR20080077625A (ko) * 2005-11-25 2008-08-25 페플린 리서치 피티이 리미티드 상처 치유 방법
CA2822360A1 (fr) 2010-12-22 2012-06-28 Leo Laboratories Limited Ingenol-3-acylates i
CA2822312A1 (fr) * 2010-12-22 2012-06-28 Gunnar Grue-Sorensen 3-acyl-ingenols ii
AU2013283511B2 (en) * 2012-06-26 2017-10-26 Leo Laboratories Limited 3-O-heteroaryl-ingenol
US12502369B2 (en) 2015-11-11 2025-12-23 K-Gen, Inc. Methods of cancer treatment
CN107164422B (zh) * 2016-03-08 2021-01-22 复旦大学 续随子二萜醇衍生物的转化方法及其在制备抗肿瘤药物中的用途
CN107164421B (zh) * 2016-03-08 2021-01-26 复旦大学 羟基化续随子二萜烷型衍生物的转化方法及其在制备抗肿瘤药物中的用途
WO2017156350A1 (fr) 2016-03-09 2017-09-14 K-Gen, Inc. Méthodes de traitement du cancer

Also Published As

Publication number Publication date
NO800148L (no) 1980-07-24
EP0013983A3 (en) 1981-03-25
DK26180A (da) 1980-07-24
CA1160953A (fr) 1984-01-24
YU17880A (en) 1983-01-21
EP0013983B1 (fr) 1984-07-04
ZA80403B (en) 1981-01-28
IE50419B1 (en) 1986-04-16
MC1298A1 (fr) 1980-10-03
US4716179A (en) 1987-12-29
AU5486080A (en) 1980-07-31
ATE8203T1 (de) 1984-07-15
EP0013983A2 (fr) 1980-08-06
DE2902506A1 (de) 1980-07-24
AU529955B2 (en) 1983-06-30
JPS55136221A (en) 1980-10-23
FI800171A7 (fi) 1981-01-01
IE800132L (en) 1980-07-23

Similar Documents

Publication Publication Date Title
DD150430A5 (de) Verfahren zur herstellung von nicht oder nur gering irritierenden und/oder promovierenden diterpenalkoholen und von derivaten davon
EP0240829B1 (fr) Agent carcinostatique
DE2549783C3 (de) Triglyceride mit entzündungshemmender Wirkung
DE69627354T2 (de) Verwendung von calendula-glykosiden zur behandlung der psoriasis
EP0192056B1 (fr) Procédé de préparation de dérivés de labdane et leur usage pharmaceutique
EP0173186B1 (fr) Dérivés de flavanone
DE2308826C3 (de) Phenoxyalkancarbonsäureester von Oxyalkyltheophyllinen, Verfahren zu ihrer Herstellung und Arzneimittel
DE3033896C2 (fr)
EP0369216B1 (fr) Préparation pharmaceutique de dérivés estériques de l'hécogénine et leur utilisation pour le traitement de l'hyperplasie prostatique bénigne
DE2347576C2 (de) Bruceantin und diese Verbindung enthaltende antileukämische Mittel
DE4028945A1 (de) Kawa-kawa-extrakt, verfahren zu seiner herstellung und seine verwendung
DD259191A1 (de) Flavolignanderivate, verfahren zu deren herstellung und arzneimittel, die diese verbindungen enthalten
DE2632118B2 (de) Apovincaminolester und Verfahren zu deren Herstellung und Arzneimittel
DE3337207C2 (fr)
DE69309461T2 (de) Zusammensetzung zur Beschleunigung der Wundheilung
DE3134709A1 (de) Antineoplastisch wirkende titanverbindung und diese enthaltende arzneimittel
DE2748291A1 (de) Triglyceride, verfahren zu ihrer herstellung und ihre verwendung zur behandlung von entzuendungen
DE2351292C3 (de) 2,10-Dichlor-6-äthoxycarbonyl-12-methyl-12H-dibenzo[d,g][1,3]dioxocin und Verfahren zu dessen Herstellung sowie diese Verbindung enthaltende Arzneimittel
EP0467407B1 (fr) Dérivés de naphthaline et d'anthracène utiles comme médicaments
CH644133A5 (de) Oxydierte sterylglycosid-derivate und sie enthaltende pharmazeutische praeparate.
DE2638554A1 (de) Choleretika
DE1922192C2 (de) Zusammensetzungen zur Behandlung von trophischen Störungen der Haut und Verfahren zu ihrer Herstellung
DE3122689C2 (de) N-Trifluoracetyl-adriamycin-14-0-hemiglutarat und -hemiadipat und diese Verbindungen enthaltende pharmazeutische Zubereitungen
DE3544457A1 (de) Arzneimittel zur behandlung von leberkrankheiten
DE2609533A1 (de) Verfahren zur extraktion von wirkstoffen, insbesondere von heterosidestern, der kaffeesaeure, sowie diese verbindungen enthaltende arzneimittel